MSSV yields 7692.31% · PFE yields 6.13%● Live data
📍 MSSV pulled ahead of the other in Year 1
Combined, MSSV + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MSSV + PFE for your $10,000?
Meso Numismatics, Inc. engages in the numismatic business in the United States and internationally. The company sells coins, paper currency, bullion, and medals through live auctions. It also offers banknote scanner, an application to identify key characteristics of a banknote; and sells its products through an online store, mesocoins.com. In addition, the company provides CELLGENIC FLOW EXOSOMES; CELLGENIC MSC, which excretes growth factors, cytokines, and proteins for regeneration of tissue; CELLGENIC LUMA that is derived from human umbilical cord mesenchymal stem cells, including potent growth factors, peptides, coenzymes, minerals, amino acids, vitamins, and UV radiation reducing agents for skin revitalization; VITANOVAS that offers in-home treatments to patients in need of immune modulation to help fight infections, viruses, and diseases; GCELL RESTORE, a closed-system medical device to harness the natural and restorative capabilities of adipose tissue; CELLGENIC SVF, an isolation kit system that has the ingredients and consumables for the extraction of adipose-derived stem cells from fat; CELLGENIC BONE MARROW; and CELLGENIC Platelet Rich Plasma for healing and reducing inflammation. Further, it offers training services to doctors. The company was formerly known as Pure Hospitality Solutions, Inc. and changed its name to Meso Numismatics, Inc. in September 2018. Meso Numismatics, Inc. was founded in 1999 and is based in Boca Raton, Florida.
Full MSSV Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.